Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
In the latest session, Fate Therapeutics Inc (NASDAQ: FATE) closed at $1.47 down -12.28% from its previous closing price of $1.67. In other words, the price has decreased by -$12.28 from its previous closing price. On the day, 4.06 million shares were traded. FATE stock price reached its highest trading level at $1.625 during the session, while it also had its lowest trading level at $1.455.
Ratios:
For a deeper understanding of Fate Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.29 and its Current Ratio is at 8.29. In the meantime, Its Debt-to-Equity ratio is 0.27 whereas as Long-Term Debt/Eq ratio is at 0.25.
On June 17, 2024, Piper Sandler Upgraded its rating to Overweight which previously was Neutral and also upped its target price recommendation from $4 to $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 10 ’25 when Valamehr Bahram bought 8,705 shares for $1.54 per share.
Bressi Jerome Charles bought 5,980 shares of FATE for $9,276 on Jan 10 ’25. On Jan 10 ’25, another insider, TAHL CINDY, who serves as the Officer of the company, bought 5,654 shares for $1.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FATE now has a Market Capitalization of 166854720 and an Enterprise Value of -31086802. For the stock, the TTM Price-to-Sale (P/S) ratio is 12.41 while its Price-to-Book (P/B) ratio in mrq is 0.46. Its current Enterprise Value per Revenue stands at -2.312 whereas that against EBITDA is 0.189.
Stock Price History:
The Beta on a monthly basis for FATE is 2.04, which has changed by -0.67405766 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, FATE has reached a high of $8.83, while it has fallen to a 52-week low of $1.55. The 50-Day Moving Average of the stock is -33.45%, while the 200-Day Moving Average is calculated to be -59.19%.
Shares Statistics:
For the past three months, FATE has traded an average of 2.95M shares per day and 2664850 over the past ten days. A total of 113.88M shares are outstanding, with a floating share count of 97.96M. Insiders hold about 13.99% of the company’s shares, while institutions hold 89.17% stake in the company. Shares short for FATE as of 1734048000 were 12186948 with a Short Ratio of 3.80, compared to 1731628800 on 10388854. Therefore, it implies a Short% of Shares Outstanding of 12186948 and a Short% of Float of 12.280000000000001.
